Masami Nakai
6PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 28, 2025
Long-term safety and tolerability of brexpiprazole for Japanese patients with agitation in Alzheimer's disease dementia: A multicenter, open-label study.Yu Nakamura, Jun Adachi, Naoki Hirota
|Aug 21, 2023
Improved quality of life with fremanezumab in Japanese and Korean patients with episodic and chronic migraine: Results of two multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trials.Yasuhiko Matsumori, Miki Ishida, Katsuhiro Iba
|May 24, 2023
Fremanezumab for Episodic Migraine Prevention in Japanese Patients: Subgroup Analysis from Two International Trials.Kazumasa Saigoh, Takao Takeshima, Masami Nakai
|Apr 27, 2023
Fremanezumab for Chronic Migraine Prevention in Japanese Patients: Subgroup Analysis from Two International Trials.Kazumasa Saigoh, Takao Takeshima, Masami Nakai
|Dec 29, 2022
A multicenter, open-label, phase 3 study to evaluate the safety of fremanezumab for migraine, subcutaneously self-administered with an auto-injection device at institutional sites and at home.Koichi Hirata, Takao Takeshima, Noboru Imai
Pageof 1
Frequent Collaborators
3 joint publications
Nobuyuki Koga
1 joint publications
Takao Takeshima
1 joint publications
Noboru Imai
1 joint publications
Muneto Tatsumoto
1 joint publications
Chihiro Osawa
1 joint publications
Jun Adachi
1 joint publications
Naoki Hirota
1 joint publications
Katsuhiro Iba
1 joint publications
Koichi Shimizu
1 joint publications
Naoki Mori
